Critical Care Diagnostics, Inc.
Records under this name other than the patents Critical Care Diagnostics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
Back to Critical Care Diagnostics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,340,222 | Test apparatus and methods for ST2 cardiac biomarker Lapsed on the fee record Ended May 24, 2026 · USPTO record | Lapsed on the fee record | Ended May 24, 2026 | USPTO record |
| US 11,340,236 | Methods for Treating or Predicting Risk of a Ventricular Tachyarrhythmia Event Formerly held Lapsed on the fee record Ended May 24, 2026 · High confidence | Lapsed on the fee record | Ended May 24, 2026 | High confidence |
| US 8,728,742 | Methods Predicting Risk of an Adverse Clinical Outcome Lapsed on the fee record Ended May 20, 2026 · High confidence | Lapsed on the fee record | Ended May 20, 2026 | High confidence |
| US 8,617,825 | Predicting mortality and detecting severe disease Lapsed on the fee record Ended Dec 31, 2025 · USPTO record | Lapsed on the fee record | Ended Dec 31, 2025 | USPTO record |
| US 9,823,257 | Methods of Treating or Selecting a Treatment for a Subject Having Heart Failure That Include Detecting Levels of GALECTIN-3 and Soluble ST2 Lapsed on the fee record Ended Nov 21, 2025 · Medium confidence | Lapsed on the fee record | Ended Nov 21, 2025 | Medium confidence |
| US 11,016,103 | Predicting mortality and detecting severe disease Lapsed on the fee record Ended May 25, 2025 · USPTO record | Lapsed on the fee record | Ended May 25, 2025 | USPTO record |
| US 8,420,785 | Soluble human ST-2 antibodies and assays Lapsed on the fee record Ended Apr 16, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 16, 2025 | USPTO record |
| US 10,928,393 | Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy Lapsed on the fee record Ended Feb 23, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 23, 2025 | USPTO record |
| US 10,741,290 | Multimarker risk stratification Lapsed on the fee record Ended Aug 11, 2024 · USPTO record | Lapsed on the fee record | Ended Aug 11, 2024 | USPTO record |
| US 10,408,845 | Methods for Treating or Predicting Risk of a Ventricular Tachyarrhythmia Event Formerly held Lapsed on the fee record Ended Sep 10, 2023 · High confidence | Lapsed on the fee record | Ended Sep 10, 2023 | High confidence |